<DOC>
	<DOCNO>NCT00166270</DOCNO>
	<brief_summary>This prospective , nonrandomized , multi-center study evaluate safety effectiveness ExAblate treatment uterine fibroid . All patient treat follow 36 month evaluate change fibroid symptom .</brief_summary>
	<brief_title>MR Guided Focused Ultrasound Surgery Treatment Uterine Fibroids</brief_title>
	<detailed_description>After PMA Panel , sponsor request conduct post-approval study . The objective study gather additional data evaluate safety long term effectiveness focus ultrasound treatment , include large cohort African-American patient . Patients treat follow approved commercial treatment guideline . Uterine leiomyoma ( fibroid ) common neoplasms female pelvis . These benign tumor generally oval shape , often highly vascular . On T2 weight MR image exam , T1 exams contrast , uterine fibroid easily identifiable . They occur 20-25 % woman reproductive age cause variety problem generally describe either bleed mass effect fibroid . In general , symptom classify two category : 1. heavy menstrual bleeding , define bleed heavy day require change sanitary wear every 2 hour less , significant clot passage , flooding , substantial prolongation menstrual period compare patient 's prior experience , anemia . 2. pelvic pain pressure , heaviness discomfort , similar symptom back , flank leg attributable bulk fibroid , urinary frequency , increase nocturia , difficulty void compression ureter hydronephrosis . Measures clinical success patient elect treatment fibroid generally subjective , evaluated patient term improvement initial symptom cause seek treatment ( decrease pain , bladder bowel symptom , reduction vaginal bleeding ) , experience minimum co-morbidities treatment .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Women present symptomatic uterine fibroid seek treatment reason improve fertility . Able willing give consent able attend study visit . Patient pre perimenopausal ( within 12 month last menstrual period ) . Able communicate sensation ExAblate procedure . Uterine fibroid , device accessible ( i.e. , position uterus access without shielded bowel bone ) . Fibroids ( ) clearly visible noncontrast MRI . Metallic implant incompatible MRI Sensitive MRI contrast agent Severe claustrophobia would prevent completion procedure MR unit Who pregnant desire become pregnant future . Pregnancies follow ExAblate treatment could dangerous mother fetus . Pedunculated fibroid Active pelvic inflammatory disease ( PID ) Active local systemic infection Known suspect pelvic carcinoma premalignant condition , include sarcoma adenomatous hyperplasia Intrauterine device ( IUD ) anywhere treatment path Dermoid cyst ovary anywhere treatment path Extensive abdominal scarring avoid redirection beam ( e.g. , due Caesarean section repeat abdominal surgery ) Undiagnosed vaginal bleeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Fibroids</keyword>
	<keyword>ExAblate</keyword>
	<keyword>MrgFus</keyword>
	<keyword>Uterine Fibroids</keyword>
</DOC>